HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Policy

IRA, state PBM reform, Medicare, and regulatory action

Texas Emerges as Focus of New Trump Administration Actions to Limit Gender-Affirming Care
PolicyKFF Health News ↗
This analysis explores recent actions the Trump administration has taken to limit youth access to gender-affir…
May 21, 2026
Understanding Medicaid Cost Sharing and Policy Changes from the 2025 Reconciliation Law
PolicyKFF Health News ↗
This brief explains current Medicaid cost sharing rules and changes made to cost sharing rules by the 2025 rec…
May 21, 2026
China’s biotech rise sparks new US industry alliance
PolicyPharmaVoice ↗
The nonprofit is aiming to inspire a new moonshot effort that helps the U.S. maintain its position as a drug i…
May 21, 2026
Takeda slapped with $885M verdict in pay-for-delay antitrust case
PolicyFiercePharma ↗
Takeda plans to appeal after a federal jury found it liable in a landmark pay-for-delay antitrust case and ord…
May 21, 2026
Overview of President Trump’s Executive Actions Impacting LGBTQ+ Health
PolicyKFF Health News ↗
This tracker examines Executive Actions taken by the Trump administration that have the potential to impact LG…
May 20, 2026
PolicyAJMC ↗
May 20, 2026
← Newer Page 2 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.